This is the Continuous Integration Build of FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions
Patient Care Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: No defined compartments |
Raw XML (canonical form + also see XML Format Specification)
Example of conditiondefinition (id = "example")
<?xml version="1.0" encoding="UTF-8"?> <ConditionDefinition xmlns="http://hl7.org/fhir"> <id value="example"/> <text> <status value="extensions"/> <div xmlns="http://www.w3.org/1999/xhtml"><p> <b> Generated Narrative: ConditionDefinition</b> <a name="example"> </a> <a name="hcexample"> </a> </p> <div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource ConditionDefinition "example" </p> </div> <p> <b> StructureDefinition Work Group</b> : pc</p> <p> <b> url</b> : <code> http://hl7.org/fhir/ConditionDefinition/example</code> </p> <p> <b> identifier</b> : <a href="http://terminology.hl7.org/5.5.0/NamingSystem-uri.html" title="As defined by RFC 3986 (http://www.ietf.org/rfc/rfc3986.txt)(with many schemes defined in many RFCs). For OIDs and UUIDs, use the URN form (urn:oid:(note: lowercase) and urn:uuid:). See http://www.ietf.org/rfc/rfc3001.txt and http://www.ietf.org/rfc/rfc4122.t xt This oid is used as an identifier II.root to indicate the the extension is an absolute URI (technically, an IRI). Typically, this is used for OIDs and GUIDs. Note that when this OID is used with OIDs and GUIDs, the II.extension should start with urn:oid or urn:uuid: Note that this OID is created to aid with interconversion between CDA and FHIR - FHIR uses urn:ietf:rfc:3986 as equivalent to this OID. URIs as identifiers appear more commonly in FHIR. This OID may also be used in CD.codeSystem.">URI</a> /urn:oid:2.16.840.1.113883.4.642.25.1</p> <p> <b> name</b> : Hyperlipidemia</p> <p> <b> title</b> : Hyperlipidemia Status</p> <p> <b> status</b> : draft</p> <p> <b> date</b> : 2019-05-26T10:44:00+10:00</p> <p> <b> publisher</b> : HL7 International / Patient Care</p> <p> <b> contact</b> : </p> <p> <b> description</b> : Hyperlipidemia Status</p> <p> <b> code</b> : Hyperlipidemia (disorder) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a> #55822004)</span> </p> <p> <b> hasSeverity</b> : false</p> <p> <b> hasBodySite</b> : false</p> <p> <b> hasStage</b> : false</p> <p> <b> definition</b> : <a href="https://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol .pdf">https://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol .pdf</a> </p> <p> <b> observation</b> : <a href="http://example.org/fhir/ObservationDefinition/lipid-panel">http://example.org/fhir/ObservationDefinition/lipid-panel</a> , <a href="http://example.org/fhir/ObservationDefinition/cholesterol">http://example.org/fhir/ObservationDefinition/cholesterol</a> , <a href="http://example.org/fhir/ObservationDefinition/triglyceride">http://example.org/fhir/ObservationDefinition/triglyceride</a> , <a href="http://example.org/fhir/ObservationDefinition/cholesterol-hdl">http://example.org/fhir/ObservationDefinition/cholesterol-hdl</a> , <a href="http://example.org/fhir/ObservationDefinition/cholesterol-ldl">http://example.org/fhir/ObservationDefinition/cholesterol-ldl</a> </p> <h3> Medications</h3> <table class="grid"><tr> <td style="display: none">-</td> <td> <b> Code</b> </td> </tr> <tr> <td style="display: none">*</td> <td> Gemfibrozil <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.5.0/CodeSystem-v3-rxNorm.html">RxNorm</a> #203151 "fenoldopam mesylate")</span> </td> </tr> </table> <h3> Plans</h3> <table class="grid"><tr> <td style="display: none">-</td> <td> <b> Reference</b> </td> </tr> <tr> <td style="display: none">*</td> <td> <a href="broken-link.html">http://acme.com/fhir/PlanDefinition/fd0e32d8-2ebd-4211-9e50-8983efddc2c6</a> </td> </tr> </table> </div> </text> <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-wg"><valueCode value="pc"/> </extension> <url value="http://hl7.org/fhir/ConditionDefinition/example"/> <identifier> <system value="urn:ietf:rfc:3986"/> <value value="urn:oid:2.16.840.1.113883.4.642.25.1"/> </identifier> <name value="Hyperlipidemia"/> <title value="Hyperlipidemia Status"/> <status value="draft"/> <date value="2019-05-26T10:44:00+10:00"/> <publisher value="HL7 International / Patient Care"/> <contact> <telecom> <system value="url"/> </telecom> </contact> <description value="Hyperlipidemia Status"/> <code> <coding> <system value="http://snomed.info/sct"/> <code value="55822004"/> <display value="Hyperlipidemia (disorder)"/> </coding> </code> <hasSeverity value="false"/> <hasBodySite value="false"/> <hasStage value="false"/> <definition value="https://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol .pdf"/> <observation value="http://example.org/fhir/ObservationDefinition/lipid-panel"/> <observation value="http://example.org/fhir/ObservationDefinition/cholesterol"/> <observation value="http://example.org/fhir/ObservationDefinition/triglyceride"/> <observation value="http://example.org/fhir/ObservationDefinition/cholesterol-hdl"/> <observation value="http://example.org/fhir/ObservationDefinition/cholesterol-ldl"/> <!-- <observation> <code> <coding> <system value="http://loinc.org"/> <code value="24331-1"/> <display value="Lipid 1996 panel - Serum or Plasma"/> </coding> <text value="Lipid Panel"/> </code> </observation> <observation> <code> <coding> <system value="http://loinc.org"/> <code value="35200-5"/> <display value="Cholesterol [Mass or Moles/volume] in Serum or Plasma"/> </coding> <text value="Cholesterol"/> </code> </observation> <observation> <code> <coding> <system value="http://loinc.org"/> <code value="35217-9"/> <display value="Triglyceride [Mass or Moles/volume] in Serum or Plasma"/> </coding> <text value="Triglyceride"/> </code> </observation> <observation> <code> <coding> <system value="http://loinc.org"/> <code value="2085-9"/> <display value="Cholesterol in HDL [Mass/volume] in Serum or Plasma"/> </coding> <text value="Cholesterol in HDL"/> </code> </observation> <observation> <code> <coding> <system value="http://loinc.org"/> <code value="13457-7"/> <display value="Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation"/> </coding> <text value="LDL Chol. (Calc)"/> </code> </observation> --> <medication> <code> <coding> <system value="http://www.nlm.nih.gov/research/umls/rxnorm"/> <code value="203151"/> <display value="fenoldopam mesylate"/> </coding> <text value="Gemfibrozil"/> </code> </medication> <plan> <reference> <reference value="http://acme.com/fhir/PlanDefinition/fd0e32d8-2ebd-4211-9e50-8983efddc2c6"/> </reference> </plan> </ConditionDefinition>
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.
FHIR ®© HL7.org 2011+. FHIR R6 hl7.fhir.core#6.0.0-cibuild generated on Thu, Apr 25, 2024 12:45+0000.
Links: Search |
Version History |
Contents |
Glossary |
QA |
Compare to R5 |
|
Propose a change